Quarterly Result19 Mar 2026, 10:49 am

Krebs Biochemicals & Industries Ltd. Announces Closure of Trading Window for Consideration of Audited Financial Results

AI Summary

Krebs Biochemicals & Industries Ltd. has announced the closure of the trading window for the consideration of audited financial results for the 4th quarter and year ended 31.03.2026. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for promoters, directors, designated persons, their immediate relatives, and all connected persons covered under the code from the close of business hours on March 31, 2026, until 48 hours after the declaration of the Audited Financial Results for the 4th quarter and year ended March 31, 2026. The date of the Board meeting for the consideration of the said Audited Financial Results will be intimated to the stock exchanges in due course of time.

Key Highlights

Krebs Biochemicals & Industries Ltd. has announced the closure of the trading window for the consideration of audited financial results.
The closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The trading window will be closed for promoters, directors, designated persons, their immediate relatives, and all connected persons covered under the code.
The closure will be effective from the close of business hours on March 31, 2026, until 48 hours after the declaration of the Audited Financial Results.
The date of the Board meeting for the consideration of the Audited Financial Results will be intimated to the stock exchanges in due course of time.

View BSE Filing

KREBSBIO

Pharmaceuticals

KREBS BIOCHEMICALS & INDUSTRIES LTD.-$

Price Impact